您的位置: 首页 > 农业专利 > 详情页

СТАБИЛЬНАЯ ЖИДКАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ КОМПЛЕКСА 3-(2,2,2-ТРИМЕТИЛГИДРАЗИНИЙ) ПРОПИОНАТ-2-ЭТИЛ-6-МЕТИЛ-3-ГИДРОКСИПИРИДИНА ДИСУКЦИНАТА, ОБЛАДАЮЩАЯ АНТИГИПОКСИЧЕСКИМ, АНТИОКСИДАНТНЫМ И АДАПТОГЕННЫМ ДЕЙСТВИЕМ
专利权人:
Общество с ограниченной ответственностью "Научно-внедренческий центр "Агроветзащита" (RU)
发明人:
Енгашев Сергей Владимирович (RU),Германов Сергей Борисович (RU),Мельниченко Владимир Иванович (RU),Жасминова Лидия Федоровна (RU),Новиков Денис Дмитриевич (RU),Енгашева Екатерина Сергеевна (RU),Токаре
申请号:
RU2013111633/15
公开号:
RU2013111633A
申请日:
2013.03.12
申请国别(地区):
RU
年份:
2014
代理人:
摘要:
1. A stable liquid pharmaceutical composition antihypoxic, antioxidative and adaptogenic effect, comprising the following components, wt.%: 2. Stable pharmaceutical composition according to claim 1, characterized in that as adjuvants preservatives, bacteriostats contains a concentration of 0.01-5.0% .3. Stable pharmaceutical composition according to claim 2, characterized in that as bacteriostatics-used preservatives sorbic acid or its pharmaceutically acceptable salts and / or benzoic acid or a pharmaceutically acceptable salt thereof and / or esters of p-hydroxybenzoic acid (parabens), and / or 1,2-propylene glycol, and / or 2-phenoxyethanol and / or benzyl alcohol and / or doxycycline (as the base or a pharmaceutically acceptable salt thereof), and / or azithromycin (as the base or a pharmaceutically acceptable salt thereof), and / or spiramycin (as base or a pharmaceutically acceptable salt thereof), and / or roxithromycin (as the base or a pharmaceutically acceptable salt thereof), and / or clarithromycin (as the base or a pharmaceutically acceptable salt thereof), and / or midecamycin (as the base or a pharmaceutically acceptable salt thereof), and / or lincomycin (in the form of a base or a pharmaceutically acceptable salt thereof), and / or clindamycin (as the base or a pharmaceutically acceptable salt thereof) and / or chloramphenicol, and / or thiamphenicol and / or florfenicol and / or ciprofloxacin (in the form of a base or pharmaceutically acceptable salt thereof), and / Benzydamine or (as the base or a pharmaceutically acceptable salt thereof), and / or terbinafine (as the base or a pharmaceutically acceptable salt thereof), and / or naftifine (as the base or a pharmaceutically acceptable salt thereof), and / or hex1. Стабильная жидкая фармацевтическая композиция с антигипоксическим, антиоксидантным и адаптогенным действием, содержащая следующие компоненты, мас.%:3-(2,2,2-триметилгидразиний) пропионат-  
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充